Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Hematology
Hematology for July/August 2017
Is Idarucizumab Safe for Dabigatran Reversal?, N Engl J Med; 2017 Aug 3; Pollack, et al
Hematology for January/February 2017
Sickle Cell Trait & HbA1c in African Americans, JAMA; 2017 Feb 7; Lacy, Wellenius, et al
Hematology for November/December 2016
Decreasing Blood Lead Levels in Americans, Am J Med; 2016 Nov; Tsoi, Cheung, et al
Hematology for November/December 2014
Sickle Cell Trait and Kidney Disease: Targeting At-Risk Patients, Early identification and intervention may preserve renal function
